PMPA nucleotide analog, oral form: Phase I and II Update

GILD began a Phase I/II study to assess safety, pharmacokinetics, tolerability and antiviral

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE